Company intelligence / Profile preview

Innovative Trauma Care

Atlanta, Georgia, United Stateslinkedin.com ↗

Ownership: Private
Development stage: Commercial

Overview

The company’s flagship product, the iTClamp®, is an FDA-cleared medical device for rapid hemorrhage control. It is designed to temporarily manage severe bleeding by sealing the skin closed at the wound site to create a stable clot until surgical repair can be performed. The iTClamp® has won industry awards and is recommended in Tactical Combat Casualty Care protocols for pre-hospital and military use. Clinical results highlight its ability to quickly stop blood loss in critical situations.

Therapeutic areas: OtherHematology
Modalities: Device
Industry: Therapeutic Medical Devices

Drug pipeline

1 asset

iTClamp

Commercial

Indications: Hemorrhage control, Trauma

Partnerships

Med Alliance International (distribution partner)

Beyond the preview

Go deeper on Innovative Trauma Care.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Innovative Trauma Care.

Explore the full profile